Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients; a Cross-Sectional Study

NCT05754047 is registered in ClinicalTrials.gov with Mahdis Bayat as lead sponsor.

NCT NCT05754047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05754047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients; a Cross-Sectional Study
Lead sponsor
Mahdis Bayat
Phase
Observational
Overall status
Completed
Start date
April 30, 1991
Completion date
March 31, 2022
Enrollment
3,582 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

her2 low breast carcinoma